About us
Sustainability
Products
Investors
Contact
Vistin Pharma ASA:
Stock exchange announcements
9/12/2022
Vistin Pharma enters into a long-term renewable energy supply agreement with Statkraft
26/10/2022
Vistin Pharma ASA: Third quarter and YTD 2022 financial results
18/10/2022
Vistin Pharma ASA: Invitation to Q3 2022 conference call
11/10/2022
Vistin Pharma ASA: Invitation to Q2 2022 conference call
19/8/2022
Vistin Pharma ASA: Second quarter and first half 2022 financial results
19/5/2022
Vistin Pharma ASA: Minutes from the annual general meeting 2022
28/4/2022
Vistin Pharma ASA: Notice of Annual General Meeting
27/4/2022
Vistin Pharma ASA: Annual Report for 2021
27/4/2022
Vistin Pharma ASA: First quarter 2022 financial results
20/4/2022
Vistin Pharma ASA: Invitation to Q1 2022 conference call
16/2/2022
New interim CEO
8/2/2022
Vistin Pharma ASA: Invitation to Q4 2021 conference call
About us
Overview
History
Vision and Value
People
Career
Sales
Sustainability
Overview
Quality
Balance by Vistin
Healthy environment
People in focus
Clean operations
Products
Overview
Products
Expansion project
Technology
Sustainability
Quality
Investors
Overview
Reasons to invest
Reports
Calendar
Corporate governance
Share information
Announcements
Contact
Overview
Contact persons
Headquarter
Manufacturing site
General Inquiry